Report Highlights
The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.
Report Includes
- 175 data tables and 50 additional tables
- An overview of the global market for in vitro toxicity testing
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to in vitro toxicity testing, accompanied by a market share analysis by toxicity endpoints, assay types, technology platforms, components, end-users, and region
- Analysis of current and future demand in the global in vitro toxicity testing, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges, and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key market participants in in vitro toxicity testing, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA, Bio‑Rad Laboratories Inc., Agilent Technologies Inc., Eurofins Scientific, Charles River Laboratories, and SGS General Surveillance Co. SA
Report Scope
This report offers a comprehensive analysis of the global in vitro toxicity testing market, including current market dynamics, emerging trends, and future growth prospects. The analysis is based on market data from 2024 as the base year, with estimates for 2025 and compound annual growth rate projections for the period from 2025 through 2030. The report evaluates both global and regional markets, providing insights into how regulatory evolution, technological innovation, and shifting industry practices are influencing demand for in vitro toxicity testing solutions.
The market is segmented by toxicity endpoint and test, including absorption, distribution, metabolism, and excretion (ADME) testing, genotoxicity testing, dermal toxicity, cytotoxicity, ocular toxicity, skin irritation, corrosion and sensitization, organ toxicity, phototoxicity testing, carcinogenicity, developmental and reproductive toxicity (DART), neurotoxicity, and other toxicity endpoints. By tool and technology, the market is segmented into cell culture technologies, high-throughput screening (HTS), multi-omics, and other emerging technologies, such as advanced in vitro models and integrated new approach methodologies.
By component, the report segments the market into equipment, reagents and kits, software and analytics, and services. By assay type, the market is segmented into cellular toxicity assays, biochemical toxicity assays, in silico assays, and other assay types, including advanced and hybrid approaches. By end-use segment, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), cosmetics and personal care companies, and other end users, including chemicals, medical devices, agrochemicals, and academic or government research institutions. By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||||
| Base year market size | $15.9 billion | ||||||||||||||||||
| Market size forecast | $28 billion | ||||||||||||||||||
| Growth rate | CAGR of 10% for the forecast period of 2025-2030 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | By Toxicity Endpoint and Test, by Tool/Technology, by Component, by Assay Type, by End-use Industry | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Middle East and Africa, South America | ||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Austria, Denmark, the Netherlands, Poland, Sweden, Switzerland, Turkey, China, Japan, India, South Korea, Australia, Malaysia, New Zealand, Singapore, Thailand, Vietnam, Brazil, Argentina, Colombia and Chile | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
||||||||||||||||||
Frequently Asked Questions (FAQs)
- Regulatory and Legislative Shift Toward Non-Animal Testing
- Cost Efficiency and Early Attrition Reduction in Drug Development
- Technological Maturation of Human-Relevant In-Vitro Platforms and Data-Driven Toxicology
- Key challenges include- Validation, Standardization, and Regulatory Acceptance Gaps, High Capital Intensity and Infrastructure Requirements
- Key opportunities include- Regulatory Enablement and Validation Services, Personalized and Precision Toxicology Using Patient-Derived In-Vitro Models
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Molecular Diagnostics: Technologies and Global Markets
The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Organ-on-a-Chip: Global Markets
The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
In Vitro Toxicity Testing: Technologies and Global Markets
The global in vitro toxicity testing market was valued at $17.4 billion in 2025 and is projected to reach $28 billion by the end of 2030, at a compound annual growth rate of 10% from 2025 to 2030.
Cardiovascular Drugs: Global Markets to 2030
The global market for cardiovascular drugs was valued at $183.7 billion in 2025 and is estimated to reach $228.6 billion by 2030, at a compound annual growth rate (CAGR) of 4.5% from 2025 through 2030.
Emerging Drugs: Global Markets
The report provides an overview of the global emerging drugs and analyzes market trends, segmented by molecule type, product type, therapeutic application, and end user. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Lung Cancer Therapeutics: Global Markets
The global market for lung cancer therapeutics is expected to grow from $32.5 billion in 2025 and is projected to reach $49.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2025 to 2030.
Global Bispecific Antibodies Market
This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data for 2022- 2024 and estimated data for the forecast period from 2025 through 2030.
Top Trending Reports
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
2025 Semiconductor Manufacturing Research Review
Explore BCC Research’s 2025 Semiconductor Manufacturing Research Review covering key market trends, technology advances, materials, packaging, wafers and growth opportunities across the industry.
2025 Fuel Cell and Battery Research Review
Discover the 2025 Fuel Cell and Battery Research Review from BCC Research with insights into market dynamics, technology advances and emerging opportunities across the sector.
Report Highlights
The global in vitro toxicity testing market should reach $13.3 billion by 2026 from $9.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
Report Includes
- 132 data tables and 30 additional tables
- An updated review of the global markets for in vitro toxicity testing and technologies under development
- Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
- Evaluation and forecast the overall market size, and corresponding market share analysis by toxicity endpoints and tests, tool/technology, component, end-user industry and geographic region
- Highlights of COVID-19 implications on the progress of this market
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Japan, China and India
- Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics and chemicals
- Insight into recent industry structure, current competitive landscape, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology testing
- Descriptive company profiles of the leading market players, including Abbott Laboratories Inc., GE Healthcare, PerkinElmer Inc., Qiagen NV and Thermo Fisher Scientific Inc.
Report Highlights
The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.
Report Includes
- 52 data table and 18 additional tables
- An overview of the global markets and technologies for the in vitro toxicity testing techniques within the pharmaceutical industry
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Information on latest trends, technological developments and government regulations that influence the growth of the market
- A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives
- Evaluation covering equipment, assays, cells, reagents, and services used in toxicity testing
- Profiles of major players in the toxicology market, including Abbott Laboratories, Inc., Agilent Technologies, Inc., Evotec AG, GE Healthcare Life Sciences and Thermo Fisher Scientific, Inc.
Report Highlights
The global in vitro toxicity testing market was valued at $4 billion in 2011 and more than $4.9 billion in 2012. This market is estimated to reach nearly $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.
Report Includes
- An overview of the global in vitro toxicity testing market, with assessments of its growth potential over the next five years and the current market scenario for alternative measures to animal testing.
- Analyses of market trends, with data from 2011 and 2012, and projections of CAGRs for the period 2012 and 2017.
- Discussion of the two major technology-based approaches, mechanistic and nonmechanistic.
- A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives.
- Profiles of major players in the industry
Report Highlights
-
The global in vitro toxicity (predictive toxicity) testing market is valued at more than $1.3 billion in 2010. With heightened awareness of animal welfare in laboratory research testing, the in vitro toxicity testing market has an anticipated value of $2.7 billion in 2015, a compound annual growth rate (CAGR) of 15% between 2010 and 2015.
-
The largest market sector is currently the cosmetics and personal-care industry, which accounts for a market share of more than 50%. This sector is currently valued at $702 million and is expected to reach $1.3 billion by 2015, a compound annual growth rate (CAGR) of 13.1%.
-
The pharmaceuticals segment is one of the most significant with a 32% market share valued at $424 million in 2010. By 2015, this sector is projected to reach a value of $976 million, a compound annual growth rate (CAGR) of 18.2%.
Report Highlights
-
The U.S. in vitro toxicity (predictive toxicity) testing market has been valued at $765 million in 2006. At a compound annual growth rate (CAGR) of 14.4%, the total U.S. market will grow to reach $1.5 billion by 2011.
-
Mechanistic toxicology testing had the highest growth through the forecast period, with an estimated CAGR of 21.8%. This sector of the market will be worth $720 million by 2011.
-
Non-mechanistic toxicology testing was the larger of the two sectors in 2006. Even with a CAGR of 9.4%, it will still maintain the majority of the market at $780 million in 2011.
Report Highlights
-
The pharmaceutical industry accounts for more than 90% of the industry.
-
In vitro toxicology growth (12.4%/year) will be higher than pharmaceutical R& D.
-
The pharmaceutical market will reach about $18.58 billion by 2007.
-
All other markets will grow 8%/year to reach $103 milion.
-
Overall, in vitro toxicology markets will see an AAGR of 12.1%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More